# Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

> **NCT01045772** · PHASE2 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 10 (actual)

## Conditions studied

- Muckle-Wells Syndrome
- Schnitzler Syndrome

## Interventions

- **DRUG:** rilonacept

## Key facts

- **NCT ID:** NCT01045772
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01045772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01045772, "Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01045772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*